286 related articles for article (PubMed ID: 31271650)
1. Tipping the scales: Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction?
Taylor LE; Ramirez LA; Musall JB; Sullivan JC
Br J Pharmacol; 2019 Nov; 176(21):4226-4242. PubMed ID: 31271650
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in mechanisms of arterial stiffness.
DuPont JJ; Kenney RM; Patel AR; Jaffe IZ
Br J Pharmacol; 2019 Nov; 176(21):4208-4225. PubMed ID: 30767200
[TBL] [Abstract][Full Text] [Related]
3. Immunity and hypertension: New targets to lighten the pressure.
Vinh A; Drummond GR; Sobey CG
Br J Pharmacol; 2019 Jun; 176(12):1813-1817. PubMed ID: 31127619
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in obesity-induced hypertension and vascular dysfunction: a protective role for estrogen in adipose tissue inflammation?
Taylor LE; Sullivan JC
Am J Physiol Regul Integr Comp Physiol; 2016 Oct; 311(4):R714-R720. PubMed ID: 27511280
[TBL] [Abstract][Full Text] [Related]
5. The importance of sex differences in pharmacology research.
Gogos A; Langmead C; Sullivan JC; Lawrence AJ
Br J Pharmacol; 2019 Nov; 176(21):4087-4089. PubMed ID: 31769019
[TBL] [Abstract][Full Text] [Related]
6. Metabolic control and sex: A focus on inflammatory-linked mediators.
Henstridge DC; Abildgaard J; Lindegaard B; Febbraio MA
Br J Pharmacol; 2019 Nov; 176(21):4193-4207. PubMed ID: 30820935
[TBL] [Abstract][Full Text] [Related]
7. Targeting inflammation to reduce cardiovascular disease risk.
Maffia P; Cirino G
Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
[TBL] [Abstract][Full Text] [Related]
8. Sex as a biological variable in the pathology and pharmacology of neurodegenerative and neurovascular diseases.
Honarpisheh P; McCullough LD
Br J Pharmacol; 2019 Nov; 176(21):4173-4192. PubMed ID: 30950038
[TBL] [Abstract][Full Text] [Related]
9. Childhood adversity and mechanistic links to hypertension risk in adulthood.
Obi IE; McPherson KC; Pollock JS
Br J Pharmacol; 2019 Jun; 176(12):1932-1950. PubMed ID: 30656638
[TBL] [Abstract][Full Text] [Related]
10. GPCRs in context: sexual dimorphism in the cardiovascular system.
Mouat MA; Coleman JLJ; Smith NJ
Br J Pharmacol; 2018 Nov; 175(21):4047-4059. PubMed ID: 29451687
[TBL] [Abstract][Full Text] [Related]
11. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.
Woodward L; Akoumianakis I; Antoniades C
Br J Pharmacol; 2017 Nov; 174(22):4007-4020. PubMed ID: 27629236
[TBL] [Abstract][Full Text] [Related]
12. Th1-type immune responses to Porphyromonas gingivalis antigens exacerbate angiotensin II-dependent hypertension and vascular dysfunction.
Czesnikiewicz-Guzik M; Nosalski R; Mikolajczyk TP; Vidler F; Dohnal T; Dembowska E; Graham D; Harrison DG; Guzik TJ
Br J Pharmacol; 2019 Jun; 176(12):1922-1931. PubMed ID: 30414380
[TBL] [Abstract][Full Text] [Related]
13. Immune cell trafficking, lymphatics and hypertension.
Balasubbramanian D; Lopez Gelston CA; Rutkowski JM; Mitchell BM
Br J Pharmacol; 2019 Jun; 176(12):1978-1988. PubMed ID: 29797446
[TBL] [Abstract][Full Text] [Related]
14. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?
Welsh P; Grassia G; Botha S; Sattar N; Maffia P
Br J Pharmacol; 2017 Nov; 174(22):3898-3913. PubMed ID: 28409825
[TBL] [Abstract][Full Text] [Related]
15. The role of the mineralocorticoid receptor in immune cells in cardiovascular disease.
van der Heijden CDCC; Bode M; Riksen NP; Wenzel UO
Br J Pharmacol; 2022 Jul; 179(13):3135-3151. PubMed ID: 34935128
[TBL] [Abstract][Full Text] [Related]
16. Sex bias in preclinical research and an exploration of how to change the status quo.
Karp NA; Reavey N
Br J Pharmacol; 2019 Nov; 176(21):4107-4118. PubMed ID: 30418665
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in schizophrenia, bipolar disorder, and post-traumatic stress disorder: Are gonadal hormones the link?
Gogos A; Ney LJ; Seymour N; Van Rheenen TE; Felmingham KL
Br J Pharmacol; 2019 Nov; 176(21):4119-4135. PubMed ID: 30658014
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in mouse models of fear inhibition: Fear extinction, safety learning, and fear-safety discrimination.
Clark JW; Drummond SPA; Hoyer D; Jacobson LH
Br J Pharmacol; 2019 Nov; 176(21):4149-4158. PubMed ID: 30710446
[TBL] [Abstract][Full Text] [Related]
19. Human obesity and endothelium-dependent responsiveness.
Campia U; Tesauro M; Cardillo C
Br J Pharmacol; 2012 Feb; 165(3):561-73. PubMed ID: 21895631
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of hypertension in autoimmune rheumatic diseases.
Taylor EB; Wolf VL; Dent E; Ryan MJ
Br J Pharmacol; 2019 Jun; 176(12):1897-1913. PubMed ID: 30714094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
